Cooper PE Ratio 2006-2019 | COO

Current and historical p/e ratio for Cooper (COO) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cooper PE ratio as of April 19, 2019 is 24.22.
Cooper PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-04-18 281.22 38.26
2019-01-31 278.76 $7.35 37.93
2018-10-31 258.28 $2.78 92.91
2018-07-31 260.47 $2.54 102.55
2018-04-30 228.66 $2.60 87.95
2018-01-31 244.61 $3.49 70.09
2017-10-31 240.17 $7.52 31.94
2017-07-31 243.78 $6.97 34.98
2017-04-30 200.24 $6.67 30.02
2017-01-31 184.52 $6.07 30.40
2016-10-31 175.93 $5.59 31.47
2016-07-31 182.35 $5.11 35.69
2016-04-30 152.96 $4.23 36.16
2016-01-31 131.04 $3.94 33.26
2015-10-31 152.20 $4.14 36.76
2015-07-31 176.81 $4.02 43.98
2015-04-30 177.85 $4.91 36.22
2015-01-31 157.46 $5.30 29.71
2014-10-31 163.67 $5.52 29.65
2014-07-31 160.65 $6.04 26.60
2014-04-30 131.70 $6.03 21.84
2014-01-31 124.08 $5.93 20.92
2013-10-31 128.97 $5.96 21.64
2013-07-31 127.12 $6.27 20.27
2013-04-30 110.17 $5.84 18.87
2013-01-31 101.14 $5.44 18.59
2012-10-31 95.75 $5.06 18.92
2012-07-31 75.08 $4.75 15.81
2012-04-30 87.93 $4.17 21.09
2012-01-31 71.94 $3.78 19.03
2011-10-31 69.08 $3.62 19.08
2011-07-31 76.25 $3.50 21.78
2011-04-30 74.63 $3.58 20.85
2011-01-31 57.14 $2.95 19.37
2010-10-31 49.14 $2.43 20.22
2010-07-31 38.70 $2.06 18.79
2010-04-30 38.70 $1.68 23.04
2010-01-31 35.15 $2.12 16.58
2009-10-31 27.85 $2.21 12.60
2009-07-31 27.29 $2.20 12.40
2009-04-30 28.56 $2.11 13.53
2009-01-31 18.84 $1.82 10.35
2008-10-31 16.34 $1.44 11.35
2008-07-31 33.42 $0.28 119.36
2008-04-30 34.68 $0.06 578.04
2008-01-31 39.02 $-0.20 0.00
2007-10-31 41.59 $-0.23 0.00
2007-07-31 49.64 $0.58 85.58
2007-04-30 50.57 $0.85 59.49
2007-01-31 47.20 $1.15 41.05
2006-10-31 56.99 $1.42 40.14
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.885B $2.533B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.317B 20.37
Align Technology (ALGN) United States $22.518B 57.33
McKesson (MCK) United States $21.887B 8.52
AmerisourceBergen (ABC) United States $15.293B 11.09
Laboratory Of America Holdings (LH) United States $14.330B 13.18
Cardinal Health (CAH) United States $13.709B 9.24
DENTSPLY SIRONA (XRAY) United States $11.127B 24.74
Henry Schein (HSIC) United States $9.192B 14.86
West Pharmaceutical Services (WST) United States $8.223B 39.69
Merit Medical Systems (MMSI) United States $3.170B 34.12
CONMED (CNMD) United States $2.242B 36.43
Patterson (PDCO) United States $2.031B 16.05
Atrion (ATRI) United States $1.612B 47.31
STAAR Surgical (STAA) United States $1.380B 115.59
Antares Pharma (ATRS) United States $0.437B 0.00
Invacare (IVC) United States $0.222B 0.00
Lifevantage (LFVN) United States $0.158B 21.27
Pro-Dex (PDEX) United States $0.063B 28.64
Endologix (ELGX) United States $0.060B 0.00
Biolase (BIOL) United States $0.049B 0.00